Ελβετία - Γερμανικά - Swissmedic (Swiss Agency for Therapeutic Products)

emergent biosolutions berna gmbh - salmonella typhi viva stamm ty 21a - kapseln - salmonella typhi lebenden stamm ty 21a min.2 mia. u., antiox.: e 300, color.: e 127, excipiens für die kapsel. - aktive immunisierung gegen typhus abdominalis, ab dem vollendeten 5. lebensjahr - impfstoffe

Αυστρία - Γερμανικά - AGES (Agentur für Gesundheit und Ernährungssicherheit)

prothya biosolutions netherlands b.v. - immunglobulin -

Ευρωπαϊκή Ένωση - Γερμανικά - EMA (European Medicines Agency)

ucb pharma sa - certolizumab pegol - morbus crohn - immunsuppressiva - cimzia, in combination with methotrexate (mtx), is indicated for the treatment of moderate to severe, active rheumatoid arthritis (ra) in adult patients when the response to disease-modifying antirheumatic drugs (dmard) including methotrexate, has been inadequate. cimzia als monotherapie im falle einer unverträglichkeit gegenüber methotrexat oder wenn die fortsetzung der behandlung mit methotrexat ungeeignet ist,. cimzia has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function, when given in combination with methotrexate.

Ευρωπαϊκή Ένωση - Γερμανικά - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Γερμανία - Γερμανικά - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

teva gmbh (3086597) - tramadolhydrochlorid - lösung - teil 1 - lösung; tramadolhydrochlorid (08720) 100 milligramm

Ευρωπαϊκή Ένωση - Γερμανικά - EMA (European Medicines Agency)

hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - immunsuppressiva - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.

Βέλγιο - Γερμανικά - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

conforma - zinkoxid - salbe - zinkoxid 500 mg/g - zinc products

Βέλγιο - Γερμανικά - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

conforma - zinkoxid - salbe - zinkoxid 100 mg/g - zinc products

Βέλγιο - Γερμανικά - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

genzyme europe - humane anti-thymocyte-immunglobulin (herkunft kaninchen) - pulver zur herstellung einer infusionslösung - 5 mg/ml - humane anti-thymocyte-immunglobulin (herkunft kaninchen) 25 mg - antithymocyte immunoglobulin (rabbit)

Ευρωπαϊκή Ένωση - Γερμανικά - EMA (European Medicines Agency)

recordati rare diseases - zink - hepatolentikuläre degeneration - anderen verdauungstrakt und stoffwechsel-produkte, - behandlung der wilson-krankheit.